40 studies
-
Does a diverse whole-food plant-based dietary intervention improve gut microbiome composition, gut symptoms, energy and hunger in healthy adults? A randomised controlled trial
- Authors
- Creedon et al.
- Journal
- British Journal of Nutrition (2026)
- Study type
- Randomized controlled trial, 321 participants
- Finding
- Mixed
Conclusion
In 321 healthy adults with low fiber intake, six weeks of a 30-plant blend changed more gut bacteria species than croutons or a probiotic. The main comparison of whether those changes favored healthier species was not significant, though energy, happiness and some digestive symptoms improved slightly versus croutons.
Why it matters
Adds a randomized test of a plant-variety product, but the changes were small and their health meaning is unclear. The maker, ZOE, funded it and its staff and co-founders are authors; it was short, not fully blinded, and did not study mood disorders.
-
Brief Report: Can Fecal Microbiota Transplantation Treat Depression?
- Authors
- Benterkia and Blythe
- Journal
- JGH Open (2026)
- Study type
- Review
- Finding
- Mixed
Conclusion
This review of four human studies (two small randomized trials and two case reports) of FMT for depression found that the 15-person depression trial showed FMT was feasible and well tolerated, with no significant change in depression scores. The authors conclude the clinical evidence is still preliminary.
Why it matters
It gives a quick map of the earliest human work on FMT for depression, alongside supportive animal studies. It rests on a single-database, English-only search of papers since 2016, and a handful of very small studies.
-
The Impact of Diet on the Fecal Microbiota Transplantation Success in Patients with Gastrointestinal Diseases—A Literature Review
- Authors
- Komorniak et al.
- Journal
- Nutrients (2025)
- Study type
- Review
- Finding
- Mixed
Conclusion
In a review of nine human studies (18–165 participants) adding diet to fecal transplants for gut diseases, most reported added benefit, such as remission in 65.7% vs 35.5% of ulcerative colitis patients given an anti-inflammatory diet plus transplant versus standard therapy. One trial found no benefit from added fiber.
Why it matters
Summarizes early evidence that adding fiber or an anti-inflammatory diet may improve fecal transplant results, but the underlying studies are mostly small and short, several lacked a transplant-alone comparison, and the review searched only PubMed. The authors call for large randomized trials.
-
Role of the microbiome in regulation of the immune system
- Authors
- Kim et al.
- Journal
- Allergology International (2025)
- Study type
- Review
Conclusion
This expert review of research on how gut and skin microbes shape the immune system reports consistent links between disrupted microbe communities and allergies, asthma, atopic dermatitis and worse COVID-19 outcomes. The authors say it remains unclear whether these changes drive immune problems or merely reflect them.
Why it matters
It summarizes how microbes and their by-products may guide immune development, and notes that probiotic trials often give mixed results while faecal microbiota transplants worked well for C. difficile infection. As an invited review with no described search method, it cannot show that treatments work, and one author declares industry consulting and funding.
-
Pharmaco-psychiatry and gut microbiome: A systematic review of effects of psychotropic drugs for bipolar disorder
- Authors
- Bui et al.
- Journal
- medRxiv (2025)
- Study type
- Review
- Finding
- Mixed
Conclusion
Across 12 studies of adults with bipolar disorder, medicines such as quetiapine and lithium were linked to mixed changes in gut bacteria, with both helpful and potentially harmful species becoming more common. In one study, 63% of gut bacteria from medicated patients resisted multiple antibiotics, vs 42% in healthy people.
Why it matters
It offers what the authors call the first systematic overview of how bipolar medicines relate to gut bacteria, but the studies were small, mostly observational, varied in methods, and often involved several drugs at once. The authors did no statistical pooling, and this preprint has not been peer reviewed.
-
Nutritional optimization of fecal microbiota transplantation in humans: a scoping review
- Authors
- Teigen et al.
- Journal
- Gut Microbes (2025)
- Study type
- Review
Conclusion
Across 18 papers on diet in adults who had fecal transplants, the studies varied widely and gave little detail on diet. Some suggested that adding diet or fiber improved results, but the authors say diet's effect on transplant success remains unclear.
Why it matters
It maps what is known about diet before and after fecal transplants, and calls for better diet data in future trials. As a scoping review of mixed study designs, many with no control group or dietary intake data, it cannot show whether diet improves outcomes.
-
Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation
- Authors
- Pinzi et al.
- Journal
- Cells (2025)
- Study type
- Review
- Finding
- Mixed
Conclusion
This review of research on depression and bipolar disorder describes inflammation as marking a distinct subgroup of patients. Anti-inflammatory drugs helped mainly patients with high inflammation, and probiotics and prebiotics gave modest but inconsistent benefits.
Why it matters
The review links gut bacteria, inflammation and mood, but its treatment evidence comes from other studies and covers probiotics only briefly. It is a narrative review with no pooled analysis, and two authors declared drug-company consulting ties.
-
Clinical efficacy of fecal microbiota transplantation in alleviating depressive symptoms: a meta-analysis of randomized trials
- Authors
- Zhang et al.
- Journal
- Frontiers in Psychiatry (2025)
- Study type
- Meta-analysis, 644 participants
- Finding
- Benefit
Conclusion
In 11 randomized trials with 644 people who had depressive symptoms, including people with irritable bowel syndrome, Parkinson's disease or major depression, FMT lowered depression scores more than placebo or standard drug treatment. The effect shrank when three outlying trials were left out and faded by 6 months.
Why it matters
It pools the randomized evidence on FMT for depressive symptoms, though only one included trial enrolled people with major depression. Limits: results varied widely between trials, and the authors rate the certainty of the evidence as low to very low.
-
Bipolar Disorder can be Managed by FMT
- Authors
- Pushkala and Gupta
- Journal
- Clinical Trials and Case Studies (2025)
- Study type
- Review
- Finding
- Benefit
Conclusion
In this narrative review of gut bacteria and bipolar disorder, the authors describe two single-patient reports in which fecal transplants were followed by reported improvement, and conclude that transplants may be an option for treatment-resistant bipolar disorder.
Why it matters
Adds no new patient data. It summarizes earlier work, and the only transplant evidence it describes comes from single-patient reports with no comparison group. The authors say clinical trials are limited, and the article does not describe how studies were selected.
-
What defines a healthy gut microbiome?
- Authors
- Van Hul et al.
- Journal
- Gut (2024)
- Study type
- Review
Conclusion
This expert review of gut microbiome research concludes there is still no agreed definition of a healthy gut microbiome. Markers such as diversity, what gut bacteria can do, and the chemicals they make each have limits, and the authors suggest function may say more about health than which species are present.
Why it matters
It adds a set of proposed markers and their limits rather than new data, and it tests no treatment. It is a narrative review with no stated method for choosing studies, and some authors declare patents and company ties.
-
Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review
- Authors
- Karimi et al.
- Journal
- Frontiers in Immunology (2024)
- Study type
- Review
- Finding
- Mixed
Conclusion
This literature review of published studies, not a new trial, concludes that fecal microbiota transplantation is generally safe and reports cure rates of 80–90%. Results were inconsistent in other conditions, including diabetes and psoriatic arthritis, where one trial found placebo did better.
Why it matters
It gives a broad overview but says nothing about how studies were searched for, selected or quality-checked, and it leans on case reports, small studies and animal work. Its headline cure rate is not broken down by condition.
-
Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review
- Authors
- Garg and Mohajeri
- Journal
- Brain Research Bulletin (2024)
- Study type
- Review
Conclusion
In a review of published human studies of people taking metformin, statins, acid-reducing drugs, anti-inflammatory painkillers and antidepressants, each drug was linked to changes in gut bacteria, some rising and some falling. Some changes resembled those seen in depression, multiple sclerosis, Parkinson's and Alzheimer's, but the authors say the evidence is not yet strong enough for firm conclusions.
Why it matters
It adds a side-by-side comparison of how common drugs shift gut bacteria and how that overlaps with microbiome changes in brain diseases, but the overlap is a hypothesis. Limits: it summarizes small, varied studies (5–25 people for metformin) that often did not account for other medicines, diet or age.
-
Is a vegetarian diet beneficial for bipolar disorder? Relationship between dietary patterns, exercise and pharmacological treatments with metabolic syndrome and course of disease in bipolar disorder
- Authors
- Gomes da Costa et al.
- Journal
- Acta Psychiatrica Scandinavica (2024)
- Study type
- Cross-sectional study, 66 participants
- Finding
- Benefit
Conclusion
In 66 people with bipolar disorder who were stable or mildly depressed, closer Mediterranean diet adherence went with better quality of life. A vegetarian-style eating pattern went with lower depression scores, better daily functioning, and lower weight and cholesterol.
Why it matters
One of few studies of diet in bipolar disorder. It compares people at one point in time, so it cannot show that diet caused the differences, and the group was small.
-
Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
- Authors
- Zhang et al.
- Journal
- Frontiers in Cellular and Infection Microbiology (2024)
- Study type
- Review
- Finding
- Benefit
Conclusion
This review of mostly animal and small human studies of diabetes found that fecal transplants from healthy donors were reported to improve blood sugar and related measures, with no obvious harm reported. The authors say large randomized trials are still lacking.
Why it matters
It gathers the animal and early human evidence on fecal transplants for diabetes in one place. Its limits: no stated method for choosing studies, human studies described are small (1 to 61 patients), and the authors say larger trials, donor choice and dosing still need study.
-
Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial
- Authors
- Green et al.
- Journal
- Pilot and Feasibility Studies (2023)
- Study type
- Other
Conclusion
This is a plan, not results: 15 adults with moderate-to-severe depression will be randomly assigned to four FMT or placebo enemas over four days, followed for 8 weeks plus 26 more weeks for safety. The main aims are to test whether this is feasible and safe.
Why it matters
It documents how this small pilot was designed, including a placebo enema and blinding, but reports no outcomes, so it cannot show whether FMT helps depression. Microbiome testing is company-supported.
-
Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans
- Authors
- Shtossel et al.
- Journal
- Microbiome (2023)
- Study type
- Other
Conclusion
Using stool data from 12 mouse and human transplant cohorts plus 48 antibiotic-treated mice, a model based only on donor bacteria predicted recipients' post-transplant gut diversity, and donors predicted to yield higher diversity did so in mice. It predicted clinical improvement only modestly (about 0.7 on a scale where 0.5 is chance and 1 perfect).
Why it matters
It suggests donors might be chosen by their gut bacteria alone, without recipient information, but this is mostly a computer study on past data. Only mice were tested prospectively, no patients were transplanted with predicted donors, and the proposed bacterial mixtures exist only as simulations.
-
Psychobiotics and fecal microbial transplantation for autism and attention-deficit/hyperactivity disorder: microbiome modulation and therapeutic mechanisms
- Authors
- Kwak et al.
- Journal
- Frontiers in Cellular and Infection Microbiology (2023)
- Study type
- Review
- Finding
- Mixed
Conclusion
This review of published studies in people with autism or attention-deficit/hyperactivity disorder (ADHD) lists probiotic and fecal transplant studies that reported fewer symptoms. The authors call the clinical evidence ambiguous and equivocal, and recommend double-blind randomized trials.
Why it matters
It gives non-specialists an overview of how probiotics and fecal transplants might act through the gut-brain link. Limits: it is a narrative review, much of the mechanism work comes from animals, and several cited human studies were open-label or single-patient reports.
-
Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db/db mice
- Authors
- Chen et al.
- Journal
- BMJ Open Diabetes Research & Care (2023)
- Study type
- Animal study
- Finding
- Benefit
Conclusion
In 16 genetically diabetic mice, those given fecal transplants from healthy mice for 4 weeks had lower blood sugar, lower blood insulin and better glucose tolerance than mice given saline. Their gut bacteria also shifted toward those of the healthy donor mice.
Why it matters
It suggests possible explanations for how FMT works (changes in gut bacteria, blood chemicals, gut lining and inflammation), but these were linked to the improvement, not proven to cause it. The results come from small groups of one genetic mouse model, so they may not carry over to people.
-
Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial
- Authors
- Green et al.
- Journal
- The Canadian Journal of Psychiatry (2023)
- Study type
- Randomized controlled trial, 15 participants
Conclusion
In 15 adults with moderate-to-severe major depression, 10 received faecal transplant enemas and 5 a placebo enema alongside their usual treatment. All 15 completed the 8 weeks, no serious or severe side effects were reported, and mild-to-moderate side effects were similar in both groups (a median of 2 per person).
Why it matters
The authors describe it as the first blinded, placebo-controlled trial of FMT for depression, and it supports larger studies. It was too small to show whether FMT works, and changes in participants' other treatments may have affected depression scores.
-
Characterization of gut microbiota profile in Iranian patients with bipolar disorder compared to healthy controls
- Authors
- Rashnaei et al.
- Journal
- Frontiers in Cellular and Infection Microbiology (2023)
- Study type
- Cross-sectional study, 60 participants
Conclusion
In 30 people with bipolar disorder and 30 healthy people in Iran, every bacterial group tested was present at different levels in the two groups. Bifidobacterium was lower and Lactobacillus higher in the bipolar group, which the authors suggest may point to a link with brain function.
Why it matters
Adds a first look at gut bacteria in bipolar disorder in an Iranian sample, and it partly matches earlier studies. It is a small one-time comparison that cannot show cause; diets varied and medication use was not analyzed.
-
The Gut-Brain Axis: The effect of dysbiosis on mood disorders like anxiety and depression
- Authors
- Sangal
- Journal
- Journal of High School Science (2022)
- Study type
- Review
- Finding
- Mixed
Conclusion
This review of gut-brain research, drawing largely on mouse studies and some human trials, concludes that probiotics could help a subgroup of people with depression or anxiety. It notes that human trials have not been very successful, especially in severe depression.
Why it matters
It adds an overview linking gut bacteria to mood, but it cannot show that probiotics work: it has no stated method for choosing studies and leans heavily on mouse work. It also describes the evidence as both conclusive and disappointing in humans.
-
Microbiota-targeted interventions for mental health
- Authors
- Berding and Cryan
- Journal
- Current Opinion in Psychiatry (2022)
- Study type
- Review
- Finding
- Mixed
Conclusion
This review of recent research on gut-targeted approaches for mental health found promising but early evidence, mainly for probiotics, prebiotics and diet as add-on treatments for mood and anxiety. Studies in patient groups are scarce, and the authors say probiotics alone are not yet supported for mood disorders.
Why it matters
Gives a broad overview of six approaches, and stresses that results may depend on strain, dose and a person's own gut bacteria. It is a narrative overview, many cited trials are small or in healthy people, and the authors declare ties to food and probiotic companies.
-
Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation
- Authors
- Su et al.
- Journal
- Scientific Reports (2022)
- Study type
- Randomized controlled trial, 5 participants
- Finding
- Mixed
Conclusion
Adding three weekly rounds of oral FMT capsules to the same diet in 5 people with type 2 diabetes brought earlier weight loss and faster gut microbiome change (toward Prevotella), and HbA1c (6.9% to 5.9%) and systolic blood pressure (133 to 109 mmHg) fell by day 20. However, clinical changes did not differ significantly from the diet-only group, which the authors attribute to the small sample, and HbA1c partly rebounded by day 90.
Why it matters
An early test of FMT as an add-on to diet for type 2 diabetes: it suggests FMT may speed up microbiome change and soften the diet-related drop in microbial diversity, with no adverse reactions reported, but it shows no added clinical benefit yet. With only 5 FMT patients (3 dropped out) and no placebo, it is best treated as a pilot.
-
Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation
- Authors
- Su et al.
- Journal
- Scientific Reports (2022)
- Study type
- Randomized controlled trial, 8 participants
- Finding
- Benefit
Conclusion
In 8 people with type 2 diabetes, 90 days of a diet supplemented with probiotics, prebiotic fiber and whole grains significantly lowered BMI (24.8 to 23.4), HbA1c (8.3% to 6.6%) and systolic blood pressure (135 to 118 mmHg) compared with baseline. Fasting blood glucose fell sharply during the first 20 days (9.6 to 6.7 mmol/L) and partly rebounded by day 90, while Bifidobacterium increased and the sulfate-reducing bacterium Bilophila decreased.
Why it matters
Supports the idea that a fiber- and probiotic-rich diet can improve blood sugar control in type 2 diabetes alongside a shift toward bacteria considered beneficial. But it is a very small open-label study with no untreated comparison group, the first 20 days were a supervised hospital stay, and it was funded in part by the company that makes the diet products.
-
Gut Microbiota – A Potential Contributor in the Pathogenesis of Bipolar Disorder
- Authors
- Zhang et al.
- Journal
- Frontiers in Neuroscience (2022)
- Study type
- Review
Conclusion
This review of 16 studies of people with bipolar disorder found that their gut bacteria often differed from those of healthy people, including lower diversity in several studies. The authors suggest gut-targeted treatments such as probiotics, diet and fecal transplant may help, but say the evidence is too early for clinical use.
Why it matters
It is a narrative summary rather than new analysis, and the studies it covers mostly compared patients with healthy people at one time point, so they cannot show cause. Treatment evidence rests on a handful of studies, including one case report, and many patients were already on medication.
-
Faecal microbiota transplantation for bipolar disorder: A detailed case study
- Authors
- Parker et al.
- Journal
- Bipolar Disorders (2022)
- Study type
- Case report, 1 participants
- Finding
- Benefit
Conclusion
In one man with bipolar II disorder, a nearly six-month FMT course (a colonoscopy dose, then enemas) was followed by much milder mood swings. He stopped his mood-stabilising medicine within two months and his second medicine, quetiapine, within six.
Why it matters
It adds a detailed, day-by-day record of a second published case of FMT for bipolar disorder. Limits: one person, no control group, mood ratings kept by the patient, and antibiotics, probiotics and diet changes came alongside FMT.
-
Adverse events in fecal microbiota transplantation: a systematic review and meta-analysis
- Authors
- Rapoport et al.
- Journal
- Annals of Gastroenterology (2022)
- Study type
- Meta-analysis, 5099 participants
Conclusion
In 61 studies covering 5,099 patients treated with FMT for recurrent C. difficile infection, serious side effects linked to FMT occurred in under 1% of patients, while serious problems judged unrelated to FMT occurred in 2.9%. Minor side effects such as abdominal pain were each under 2%.
Why it matters
It pools the short-term safety record of FMT for this infection across many studies, though only 16 of the 61 were randomized and each study judged for itself whether a problem was caused by FMT. The authors note that long-term effects are not fully known.
-
The safety and efficacy of fecal microbiota transplantation in a population with bipolar disorder during depressive episodes: study protocol for a pilot randomized controlled trial
- Authors
- Cooke et al.
- Journal
- Pilot and Feasibility Studies (2021)
- Study type
- Other
Conclusion
This is a plan, not results: adults with bipolar disorder in a depressive episode will be randomly assigned to receive donor stool or their own stool by colonoscopy and followed for 24 weeks. The plan is to recruit 60 people to test feasibility, safety and early signs of benefit.
Why it matters
It shows how a planned early trial of FMT in bipolar depression is designed, including a control group that receives its own stool. It reports no outcomes, so it cannot show whether FMT helps.
-
The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies
- Authors
- Wiertsema et al.
- Journal
- Nutrients (2021)
- Study type
- Review
- Finding
- Mixed
Conclusion
This review of research on the gut microbiome and immunity from infancy to old age describes how probiotics, prebiotics and dietary fiber may help prevent or treat infections. It notes that probiotic trial results conflict, and that differences between products and between people limit firm recommendations.
Why it matters
A narrative review with no stated search method, so it reflects the authors' choice of studies; much of the mechanism work it cites is in mice. The authors are employed by a food company (Danone Nutricia Research) and declare no conflict of interest.
-
Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis
- Authors
- Nikolova et al.
- Journal
- JAMA Psychiatry (2021)
- Study type
- Meta-analysis, 2948 participants
Conclusion
In 59 studies comparing adults with psychiatric disorders to controls, patients had modestly lower gut bacterial richness. Across depression, bipolar disorder, schizophrenia and anxiety, the studies linked these conditions to fewer anti-inflammatory, butyrate-producing bacteria and more pro-inflammatory ones, rather than to disorder-specific patterns.
Why it matters
The paper suggests gut bacteria differences are shared across several disorders rather than unique to each, which weakens the case for disorder-specific gut biomarkers. The studies were observational and mostly small, so cause and effect can't be shown, and psychiatric medication and region may explain some differences.
-
Therapeutic Goods (Standard for Faecal Microbiota Transplant Products) (TGO 105) Order 2020
- Study type
- Other
Conclusion
This Australian legal standard sets rules for making faecal microbiota transplant products, including how donors are screened, how samples are tested, and how stool is processed and stored. It is a regulation, not a study, and reports no patient results.
Why it matters
It shows how these products are regulated in Australia but adds no evidence on whether they work or how safe they are for patients. Its rules cover manufacturing and donors only.
-
Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries
- Authors
- Ghosh et al.
- Journal
- Gut (2020)
- Study type
- Randomized controlled trial, 612 participants
- Finding
- Mixed
Conclusion
In 612 older adults across five European countries who were non-frail or pre-frail, a year-long Mediterranean diet did not significantly change overall gut microbial diversity versus a control group. Closer adherence was linked to less diversity loss and to gut bacteria associated with lower inflammation and frailty markers.
Why it matters
It offers candidate bacteria that respond to a Mediterranean diet and hints the microbiome may mediate diet's health effects. Most associations were weak correlations among adherers, not trial-arm comparisons, and metabolite changes were predicted from sequencing rather than measured.
-
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
- Authors
- Bibbò et al.
- Journal
- Journal of Clinical Medicine (2020)
- Study type
- Review
Conclusion
This narrative review of published studies found that fecal transplants are recommended only for recurrent C. difficile infection, where cure rates reach up to 90%, while evidence for ulcerative colitis, irritable bowel syndrome and metabolic disorders is promising but limited. Choosing donors by their gut microbes is not yet ready for routine use.
Why it matters
It brings together donor screening steps (interview, blood and stool tests) and early hints about choosing donors by microbial makeup. As a narrative review it reports no systematic search method, and much of the donor-matching evidence comes from small studies or mouse experiments.
-
The Effects of Dietary Improvement on Symptoms of Depression and Anxiety: A Meta-Analysis of Randomized Controlled Trials
- Authors
- Firth et al.
- Journal
- Psychosomatic Medicine (2019)
- Study type
- Meta-analysis, 45826 participants
- Finding
- Benefit
Conclusion
Pooling 16 randomized trials with 45,826 adults, mostly without diagnosed depression, diet programs modestly reduced depressive symptoms compared with usual diet or other activities. They did not clearly reduce anxiety across 11 trials with 2,270 people.
Why it matters
Only one trial enrolled people with diagnosed depression, so the results mostly apply to mild or subthreshold symptoms. The trials differed widely and showed signs of publication bias, and benefits appeared in women but not men, based on few studies.
-
The Gut Microbiome Composition Associates with Bipolar Disorder and Illness Severity
- Authors
- Evans et al.
- Journal
- Journal of Psychiatric Research (2017)
- Study type
- Cross-sectional study, 179 participants
Conclusion
In 115 people with bipolar disorder and 64 healthy controls, the overall mix of gut bacteria differed moderately, and Faecalibacterium was 34% lower in the bipolar group. Among those with bipolar disorder, more Faecalibacterium was linked to better self-reported physical health, depression, and sleep.
Why it matters
Adds early human evidence of a gut bacteria difference in bipolar disorder, echoing findings in depression, but it is a one-time snapshot that cannot show cause. Medications were not accounted for, outcomes were self-reported, and some authors declared industry consulting or research funding.
-
Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial
- Authors
- Kao et al.
- Journal
- JAMA (2017)
- Study type
- Randomized controlled trial, 105 participants
- Finding
- Benefit
Conclusion
In 105 adults with repeated C. difficile infections, a single FMT prevented a recurrence over 12 weeks in 96% of those given capsules and 96% of those given it by colonoscopy. Capsules were not inferior, and more capsule patients called the experience not at all unpleasant (66% vs 44%).
Why it matters
It shows a swallowed capsule can work about as well as a colonoscopy, which is far less invasive, and that gut microbial diversity rose after both routes. Limits: no placebo group, patients knew their route, severe cases were excluded, and one author reported company grants.
-
A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)
- Authors
- Jacka et al.
- Journal
- BMC Medicine (2017)
- Study type
- Randomized controlled trial, 56 participants
- Finding
- Benefit
Conclusion
In 56 adults with moderate to severe depression who finished the trial, 12 weeks of dietitian support to eat a Mediterranean-style diet was followed by remission in 32% versus 8% with social support.
Why it matters
One of the few randomized tests of a diet for depression, but it was small and single-blind, and participants were also receiving other treatment. It did not study bipolar disorder.
-
Understanding the mechanisms of faecal microbiota transplantation
- Authors
- Khoruts and Sadowsky
- Journal
- Nature Reviews Gastroenterology & Hepatology (2016)
- Study type
- Review
Conclusion
This expert review explains how donor stool may clear recurrent C. difficile infection: donor microbes compete with the germ, restore bile acids that block it, and support the gut's immune defences. The authors say benefit is clear only for this infection.
Why it matters
It sets out why FMT works for recurrent C. difficile infection, which helps in judging whether it could work for other conditions. The authors say the field is young and that other uses need more trials.
-
High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome
- Authors
- De Filippis et al.
- Journal
- Gut (2016)
- Study type
- Cross-sectional study, 153 participants
- Finding
- Benefit
Conclusion
In 153 apparently healthy Italian adults (51 omnivores, 51 vegetarians, 51 vegans), closer adherence to a Mediterranean diet went with higher stool levels of short-chain fatty acids and lower urine levels of a gut-produced compound linked to heart disease. The stool trend also held among omnivores alone.
Why it matters
It links a Mediterranean-style diet, not only vegetarian or vegan eating, to gut metabolites tied to health. It is a one-time snapshot with self-recorded diet, so it cannot show cause, and no health outcomes were measured.
-
Fecal Microbiota Transplant Protocol for Clostridium Difficile Infection
- Authors
- Tauxe et al.
- Journal
- Lab Med (2015)
- Study type
- Other
Conclusion
This paper describes how one U.S. hospital prepares and performs fecal transplants for recurrent C. difficile infection, from donor screening to follow-up. The authors report more than 125 transplants there, with over 90% success (diarrhea stopped 4 weeks after the last treatment).
Why it matters
Adds practical detail on donor screening, stool preparation and delivery. The success figure is the center's own brief summary, with no comparison group or patient-level data, and FMT was still classed as investigational.
No studies match these filters. Try removing one, or .